U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT06981455) titled 'Life Following Excision of Neuroendocrine Tumors' on April 23.
Brief Summary: Neuroendocrine tumors (NETs), often seen as "chronic cancer" present a survival paradox with relatively prolonged patient survival despite active disease. Treatment strategies emphasize management over cure, integrating tumor control with quality of life (QOL) considerations. Surgery is a cornerstone of NET management but demands a careful balance between its potential benefits and the morbidity risks. Current literature on post-surgical QOL is limited and non-generalizable, underscoring the need for comprehensive, multi-institutional data to inform surgica...